Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS

More articles from Accepted Article

  • You have accessAccepted Article
    Effectiveness of a second biologic after failure of a non-tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis
    Katerina Chatzidionysiou, Merete Lund Hetland, Thomas Frisell, Daniela Di Giuseppe, Karin Hellgren, Bente Glintborg, Dan Nordström, Ritva Peltomaa, Kalle Aaltonen, Nina Trokovic, Eirik K. Kristianslund, Tore K. Kvien, Sella A. Provan, Bjorn Gudbjornsson, Gerdur Grondal, Lene Dreyer, Lars Erik Kristensen, Tanja Schjødt Jørgensen, Lennart T.H. Jacobsson and Johan Askling
    The Journal of Rheumatology March 1 2021, jrheum.201467; DOI: https://doi.org/10.3899/jrheum.201467
  • You have accessAccepted Article
    Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
    Aladdin J. Mohammad, Aleksandra Turkiewicz, Pavlos Stamatis, Carl Turesson, Martin Englund and Ali Kiadaliri
    The Journal of Rheumatology March 1 2021, jrheum.201131; DOI: https://doi.org/10.3899/jrheum.201131
  • You have accessAccepted Article
    Relationship between the dynamics of telomere loss in peripheral blood leukocytes from osteoarthritis patients and mitochondrial DNA haplogroup
    Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco Javier Blanco García and José Luis Fernández García
    The Journal of Rheumatology March 1 2021, jrheum.201316; DOI: https://doi.org/10.3899/jrheum.201316
  • Open AccessAccepted Article
    Re-thinking Physical Activity Promotion during COVID-19 Pandemic: Focus on a 24-hour Day
    Linda C. Li, Lynne M. Feehan and Alison M. Hoens
    The Journal of Rheumatology February 15 2021, jrheum.201595; DOI: https://doi.org/10.3899/jrheum.201595
  • You have accessAccepted Article
    Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients
    Jérémy Clément, Pierre Duffau, Joel Constans, Thierry Schaeverbeke, Jean-Francois Viallard, Damien Barcar, Jean-Philippe Vernhes, Laurent Sailler and Fabrice Bonnet
    The Journal of Rheumatology February 15 2021, jrheum.200952; DOI: https://doi.org/10.3899/jrheum.200952
  • You have accessAccepted Article
    Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
    Philip S. Helliwell, William Tillett, Robin Waxman, Laura C. Coates, Mel Brooke, Oliver FitzGerald, Jonathan C. Packham and Neil McHugh on behalf of the PROMPT study group
    The Journal of Rheumatology February 15 2021, jrheum.201317; DOI: https://doi.org/10.3899/jrheum.201317
  • You have accessAccepted Article
    A phase III randomized study of apremilast, an oral phosphodiesterase 4 inhibitor, for active ankylosing spondylitis
    Peter C. Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng and Annelies Boonen
    The Journal of Rheumatology February 15 2021, jrheum.201088; DOI: https://doi.org/10.3899/jrheum.201088
  • Open AccessAccepted Article
    Multimorbidity Burden in Rheumatoid Arthritis: A Population-Based Cohort Study
    Tina M. Gunderson, Elena Myasoedova, John M. Davis III and Cynthia S. Crowson
    The Journal of Rheumatology February 15 2021, jrheum.200971; DOI: https://doi.org/10.3899/jrheum.200971
  • Open AccessAccepted Article
    Improved Incidence of Cardiovascular Disease in Patients with Incident Rheumatoid Arthritis in the 2000s: a Population-Based Cohort Study
    Elena Myasoedova, John M. Davis III, Veronique L. Roger, Sara J. Achenbach and Cynthia S. Crowson
    The Journal of Rheumatology February 15 2021, jrheum.200842; DOI: https://doi.org/10.3899/jrheum.200842
  • You have accessAccepted Article
    Efficacy of moderately dosed etoposide in macrophage activation syndrome - hemophagocytic lymphohistiocytosis (MAS-HLH)
    AnnaCarin Horne, Tatiana von Bahr Greenwood, Samuel C.C. Chiang, Marie Meeths, Caroline Björklund, Maria Ekelund, Peter Erensjö, Stefan Berg, Stefan Hagelberg, Yenan T. Bryceson, Ulf Andersson and Jan-Inge Henter
    The Journal of Rheumatology February 15 2021, jrheum.200941; DOI: https://doi.org/10.3899/jrheum.200941

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire